{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Ha SM"],"funding":["Ministry of Science and ICT","Ministry of Health & Welfare, Korea","Korea Health Industry Development Institute","BioNano Health Guard Research Center","Ministry of Science, ICT and Future Planning","National Research Foundation of Korea"],"pagination":["530-536"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC6660342"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["39(6)"],"pubmed_abstract":["Background
Next-generation sequencing is increasingly used for taxonomic identification of pathogenic bacterial isolates. We evaluated the performance of a newly introduced whole genome-based bacterial identification system, TrueBac ID (ChunLab Inc., Seoul, Korea), using clinical isolates that were not identified by three matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) systems and 16S rRNA gene sequencing.Methods
Thirty-six bacterial isolates were selected from a university-affiliated hospital and a commercial clinical laboratory. Species was identified by three MALDI-TOF MS systems: Bruker Biotyper MS (Bruker Daltonics, Billerica, MA, USA), VITEK MS (bioMérieux, Marcy l'Étoile, France), and ASTA MicroIDSys (ASTA Inc., Suwon, Kore"],"journal":["Annals of laboratory medicine"],"pubmed_title":["Application of the Whole Genome-Based Bacterial Identification System, TrueBac ID, Using Clinical Isolates That Were Not Identified With Three Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Systems."],"pmcid":["PMC6660342"],"funding_grant_id":["H-GUARD_2014M3A6B2060509","HI17C1807","2017M3A7B4039936"],"pubmed_authors":["Ha SM","Roh J","Choi SB","Byun JH","Yang SJ","Kim CK","Yong D","Chun J"],"additional_accession":[]},"is_claimable":false,"name":"Application of the Whole Genome-Based Bacterial Identification System, TrueBac ID, Using Clinical Isolates That Were Not Identified With Three Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) Systems.","description":"Background
Next-generation sequencing is increasingly used for taxonomic identification of pathogenic bacterial isolates. We evaluated the performance of a newly introduced whole genome-based bacterial identification system, TrueBac ID (ChunLab Inc., Seoul, Korea), using clinical isolates that were not identified by three matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) systems and 16S rRNA gene sequencing.Methods
Thirty-six bacterial isolates were selected from a university-affiliated hospital and a commercial clinical laboratory. Species was identified by three MALDI-TOF MS systems: Bruker Biotyper MS (Bruker Daltonics, Billerica, MA, USA), VITEK MS (bioMérieux, Marcy l'Étoile, France), and ASTA MicroIDSys (ASTA Inc., Suwon, Kore","dates":{"release":"2019-01-01T00:00:00Z","publication":"2019 Nov","modification":"2025-04-05T09:36:10.138Z","creation":"2019-11-08T08:04:12Z"},"accession":"S-EPMC6660342","cross_references":{"pubmed":["31240880"],"doi":["10.3343/alm.2019.39.6.530"]}}